Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
161M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
46.9M
-
Shares change
-
+3.59M
-
Total reported value, excl. options
-
$120M
-
Value change
-
+$9.62M
-
Put/Call ratio
-
5.25
-
Number of buys
-
35
-
Number of sells
-
-42
-
Price
-
$2.57
Significant Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q1 2024
110 filings reported holding GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share as of Q1 2024.
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.9M shares
of 161M outstanding shares and own 29.19% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (6.74M shares), BlackRock Inc. (5.79M shares), Redmile Group, LLC (5.76M shares), VANGUARD GROUP INC (4.73M shares), Versant Venture Management, LLC (3.56M shares), Point72 Asset Management, L.P. (3.07M shares), DEUTSCHE BANK AG\ (2.98M shares), GEODE CAPITAL MANAGEMENT, LLC (1.99M shares), STATE STREET CORP (1.8M shares), and Ensign Peak Advisors, Inc (1.47M shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.